Jason Smith
General Counsel
UroGen Pharma Ltd. (URGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | UroGen Pharma Ltd. (URGN) | General Counsel and Chief Compliance Officer | $492,011 | $1,198,618 |
| 2024 | UroGen Pharma Ltd. (URGN) | General Counsel and Chief Compliance Officer | $475,003 | $1,275,464 |
| 2023 | UroGen Pharma Ltd. (URGN) | General Counsel and Chief Compliance Officer | $456,733 | $1,508,179 |
| 2022 | UroGen Pharma Ltd. (URGN) | General Counsel and Chief Compliance Officer | $440,019 | $926,121 |
| 2021 | UroGen Pharma Ltd. (URGN) | General Counsel and Chief Compliance Officer | $429,260 | $1,058,671 |
| 2020 | UroGen Pharma Ltd. (URGN) | General Counsel and Chief Compliance Officer | $126,930 | $1,615,273 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.